Mercury Laboratories Ltd
NSE: BSE: 538964
₹760
(0%)
Mon, 19 Oct 2026, 01:55 am
Market Cap (in Cr)91.2
PE Ratio21.90
Dividend0.46
Health Technology
Pharmaceuticals: Major
24.5KMercury Laboratories Cashflow
| Particulars | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Deprecation and amortization | -2.79M | -2.96M | -3.22M | -8.93M | -11.81M | -11.84M | -12.89M | -14.74M | -16.28M | -18.69M | -19.21M | -24.53M | -24.83M | -28.16M | -28.76M |
| Accumulated depreciation, total | -26.69M | -28.99M | -31.98M | -40.30M | -55.78M | -67.62M | -79.59M | -92.52M | -108.44M | -126.71M | -145.19M | -165.49M | -186.35M | -206.31M | -227.10M |
| Cash from operating activities | -6.54M | 15.62M | 69.50M | 34.68M | 34.86M | -970.13K | 10.30M | 40.61M | 41.35M | 46.75M | 75.72M | 47.42M | 21.39M | 78.68M | 36.22M |
| Funds from operations | 24.33M | 25.96M | 32.16M | 47.34M | 45.10M | 47.11M | 50.67M | 32.63M | 46.53M | 49.73M | 84.62M | 55.47M | 88.71M | 85.06M | 53.67M |
| Net income (cash flow) | 20.54M | 23.07M | 25.40M | 32.22M | 33.13M | 39.23M | 27.03M | 20.13M | 28.36M | 32.28M | 53.37M | 35.62M | 55.79M | 56.54M | 31.45M |
| Depreciation & amortization (cash flow) | 2.79M | 2.96M | 3.22M | 8.93M | 11.81M | 11.84M | 12.89M | 14.74M | 16.28M | 18.69M | 19.21M | 24.53M | 24.83M | 28.16M | 28.76M |
| Depreciation/depletion | 2.79M | 2.96M | 3.22M | 8.93M | 11.81M | 11.84M | 12.15M | 13.90M | 15.92M | 18.27M | 19.04M | 24.25M | 24.61M | 27.95M | 28.66M |
| Amortization | — | — | — | — | — | — | 731.04K | 842.15K | 354.33K | 421.61K | 166.08K | 276.00K | 223.00K | 204.00K | 95.00K |
| Deferred taxes (cash flow) | 0 | 0 | 0 | 0 | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-cash items | -9.16M | -10.31M | -9.28M | -9.52M | -12.75M | -14.09M | -11.16M | -6.68M | -10.26M | -12.25M | -13.68M | -19.37M | -10.56M | -12.30M | -21.71M |
| Changes in working capital | -30.86M | -10.34M | 37.34M | -12.66M | -10.24M | -48.08M | -40.36M | 7.98M | -5.17M | -2.98M | -8.89M | -8.04M | -67.33M | -6.37M | -17.45M |
| Cash from investing activities | -2.49M | -26.24M | -116.33M | -24.84M | -15.43M | -2.79M | -15.01M | -36.79M | -49.91M | -11.41M | -46.19M | -18.92M | -10.57M | -62.72M | -90.40M |
| Capital expenditures | -2.49M | -26.62M | -116.36M | -24.92M | -15.43M | -2.79M | -15.01M | -37.17M | -49.91M | -11.41M | -46.19M | -19.14M | -10.57M | -62.72M | -90.40M |
| Capital expenditures - fixed assets | -2.49M | -26.62M | -116.36M | -24.92M | -15.43M | -2.79M | -15.01M | -37.17M | -49.91M | -11.41M | -46.19M | -19.14M | -10.57M | -62.72M | -90.40M |
| Capital expenditures - other assets | 0 | 0 | 0 | 0 | — | — | — | — | — | 0 | — | — | — | — | — |
| Cash from financing activities | 7.61M | 3.85M | 52.00M | -10.41M | -21.25M | 4.71M | 6.38M | 19.76M | -14.56M | -25.10M | -5.94M | -7.84M | -6.99M | -6.85M | -6.15M |
| Free cash flow | -9.03M | -11.00M | -46.85M | 9.76M | 19.43M | -3.76M | -4.71M | 3.44M | -8.56M | 35.34M | 29.53M | 28.28M | 10.82M | 15.97M | -54.18M |
